Daniel Weghuber
Daniel Weghuber is an expert in Pediatrics at Christian Doppler Klinik Salzburg Universitätsklinikum Der Pmu Neurocare Rehaklinik Salzburg (Austria). As of October 2026, ScienceLeadR ranks Daniel Weghuber in the top 1% of experts worldwide for Obesity, Overweight and Overnutrition. Daniel Weghuber has authored 212 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 2 of them ongoing. SLR score: 769 (community average: 125). How the SLR is computed.
LeadR Profile
Pediatrics
Subspecialties: Endocrinology - Gastroenterology - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 212
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Vitamin D status and adiposity in children with low-energy fractures: a prospective case-control study. PMID 42850326 — vitamin d, serum, vitamins, case-control studies, adiposity, pediatrics, wounds and injuries, child | Eur J Pediatr | 2026 | 0 |
| BMI, Vitamin D Status, and Biochemical Markers of Mineralization in Children with Low-Energy Fractures: A Prospective Case-Control Study. PMID 42794296 — parathyroid hormone, vitamin d, alkaline phosphatase, body mass index, vitamins, case-control studies, adiposity, calcium, wounds and injuries, child | Children (Basel) | 2026 | 0 |
| Effect of weight loss interventions on liver-related health in children and adolescents with obesity: a systematic review and meta-analyses. PMID 42420603 — liver diseases, exercise, liver, diet, adolescent, histology, obesity, weight loss, child | Int J Obes (Lond) | 2026 | 0 |
| The Use of Body Mass Index Polygenic Risk Score (BMI-PRS) in a Paediatric Population With Obesity. PMID 42386670 — body mass index, adolescent, obesity, precision medicine, genetic risk score | Pediatr Obes | 2026 | 1 |
| Obesity Management Pharmacotherapies and Lifestyle Treatment for Pediatric Obesity Management: A Systematic Review and Network Meta-Analysis. PMID 42329656 — life style, pediatric obesity, obesity management, drug therapy, adolescent, network meta-analysis, obesity, weight loss, therapeutics, pediatrics, counseling, child, weight control | JAMA Pediatr | 2026 | 2 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| STEP Young A research study on how well semaglutide helps children and teenagers with excess body weight lose weight 2022-502922-41-00 — safety, aged, adolescent, body weight, obesity, research, overweight, child, weight control, semaglutide | Phase 3 | Active not recruiting | 2023 |
| Bone Outcomes Obesity Sunlight and Trauma in Children NCT07143552 — vitamin d, alkaline phosphatase, vitamins, case-control studies, phosphoric monoester hydrolases, calcium, obesity, overweight, wounds and injuries, sunlight, vitamin d deficiency, child | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map